T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR — Stella

Home/Peripheral T Cell Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Peripheral T Cell Lymphoma trials

Trial locations(1 site)

China

Shanghai General Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Enrollment target

~58 participants

Started

October 2025

Primary completion

May 2029

Age range

18 Years – 70 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.